Search
for
Sort by
Research 451–480 of 1000+
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Treatment of Alopecia Areata With Tofacitinib
- Most men choose eyebrows versus scalp hair: Response to Mostaghimi et al., “Evaluation of eyebrow and eyelash regrowth and patient satisfaction in the phase 3 THRIVE-AA2 trial of deuruxolitinib in adult patients with alopecia areata”
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- Antioxidant and 5α-Reductase Inhibitory Activity of Momordica charantia Extract, and Development and Characterization of Microemulsion
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- JAK Inhibitors in African American Patients With Alopecia Areata: A Case Series
- Exploring novel management options for alopecia areata
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- An ERK-dependent molecular switch antagonizes fibrosis and promotes regeneration in spiny mice ( <i>Acomys</i> )
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- Platycladus orientalis Leaf Extract Promotes Hair Growth via Non-Receptor Tyrosine Kinase ACK1 Activation
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- Shedding light on therapeutics in alopecia and their relevance to COVID-19
- FRI0157 OBSERVATIONAL STUDY OF HAIR FALL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW DOSE METHOTREXATE COMPARED TO HEALTHY CONTROLS
- Gut Microbiota and Its Association with Alopecia Areata: Insights from a Two-Sample Mendelian Randomization Study
- 448 Challenges of securing insurance approval for oral tofacitinib treatment of alopecia areata: A multi-institutional retrospective review
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Alopecia universalis treated with simvastatin/ezetimibe, minoxidil, and prednisolone in a 6‐year‐old girl
- EFFECTS OF LIRAGLUTIDE ON VISCERAL ADIPOSITY INDEX IN WOMAN OF REPRODUCTIVE AGE WITH PREDIABETES
- A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
- Ivarmacitinib stimulates hair regrowth in severe alopecia areata
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Review of Baricitinib in the Treatment of Alopecia Areata.
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study